Sign In
Buy PFE
$25.69
+0.335 (+1.32%)
At Close: Jun 04, 2026
Did Novo Nordisk Just Say "Checkmate" to Pfizer?
01:23pm, Monday, 03'rd Nov 2025
Novo Nordisk made a much higher offer to acquire a biotech Pfizer was already set to buy out. Losing this battle would be more damaging to Pfizer than to Novo Nordisk.
Metsera Calls Pfizer's Claims 'Nonsense' In Latest Buyout Battle Salvo
12:42pm, Monday, 03'rd Nov 2025
Metsera called Pfizer's claims "nonsense" in a follow-up Monday to Pfizer's lawsuit against Metsera and Novo Nordisk.
Pfizer files second lawsuit against Novo Nordisk, Metsera in bidding war over obesity biotech
11:39am, Monday, 03'rd Nov 2025
Pfizer said it filed a second lawsuit against Novo Nordisk and Metsera, alleging that the Danish drugmaker's attempt to outbid Pfizer to acquire the obesity biotech is anticompetitive. The new suit
Pfizer Files Antitrust Suit to Block Novo Nordisk Acquisition of Metsera
09:19am, Monday, 03'rd Nov 2025
Lawsuit says the proposed merger of the weight-loss drugmakers could kill off a smaller competitor.
How To Earn $500 A Month From Pfizer Stock Ahead Of Q3 Earnings
08:15am, Monday, 03'rd Nov 2025
Pfizer Inc. (NYSE:PFE) will release earnings results for the third quarter before the opening bell on Tuesday, Nov. 4.
Pfizer files second lawsuit against Metsera, Novo Nordisk
08:07am, Monday, 03'rd Nov 2025
Pfizer Inc said on Monday it has filed a second lawsuit against Metsera , its controlling shareholder, and Novo Nordisk in a Delaware federal court, accusing the Danish drugmaker of anticompetitive co
Pfizer Files Federal Antitrust Claims in Second Lawsuit Against Metsera, its Controlling Stockholders and Novo Nordisk
07:57am, Monday, 03'rd Nov 2025
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. today announced that it has filed a second lawsuit against Metsera, Inc., its controlling stockholders, and Novo Nordisk A/S in the United States District Court
2 Healthcare Stocks for Individual Investors With a 20-Year Time Horizon
07:37am, Monday, 03'rd Nov 2025
A former pandemic favorite and a lesser-known biopharmaceutical stock both have value to add to a long-term investor's portfolio. Pfizer's growth has slowed from a few years ago, but its tepid stock p
Meet the 7% Yield Dividend Stock That Could Soar in 2026
04:46am, Monday, 03'rd Nov 2025
The big near-term headwind for this drug maker is upcoming patent expirations. The company is working to address the issue, with a sizable acquisition that will advance its efforts in the diet drug sp
1 Incredible Reason to Buy Pfizer Stock (PFE) in November
04:00am, Monday, 03'rd Nov 2025
Pfizer has long been a solid dividend payer, having raised its dividend annually for 16 years. Its yield is high because the stock price has fallen in recent years.
Palantir, AMD, Pfizer, and Many More Stocks to Watch
02:00pm, Sunday, 02'nd Nov 2025
Vertex, Corteva, and many more will also report earnings. On the economic front, The Supreme Court will hear arguments on the legality of Trump's tariffs, and ADP will release October employment data.
Wall Street Week Ahead
07:07am, Sunday, 02'nd Nov 2025
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Novo Nordisk and Pfizer are showing some desperation in their gloves-off tussle for the obesity-drug assets of Metsera.
Is It Time to Dump Your Shares of Pfizer?
04:20am, Sunday, 02'nd Nov 2025
After reporting record revenue a few years ago, Pfizer has faced tougher times in recent quarters. Challenges include a decline in demand for coronavirus products and patent expirations on the horizon
Top Medical Stocks To Keep An Eye On – October 31st
01:35am, Sunday, 02'nd Nov 2025
Eli Lilly and Company, Pfizer, and UnitedHealth Group are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies
